87 results
8-K
EX-10.1
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
product is depleted (and with the appropriate regulatory oversight). All newly manufactured lots under this contract will be labeled with [**] expiry
8-K
EX-10.2
n54nblgqzpusb6n08l8e
17 May 23
Emergent’s Statement Regarding its Amended Credit Agreement
9:32pm
DEFR14A
64cu4r mdcm2u34v9
24 Apr 23
Revised proxy
9:32am
8-K
bm8ddwflg1i9d37dfye2
12 Aug 22
Other Events
5:03pm
8-K
EX-99
pelfsgoobv7nq8 rbx3e
12 Aug 22
Other Events
5:03pm
8-K/A
EX-99.1
6taq9d7ewwn3nqmqup
2 Aug 22
Emergent Biosolutions Reports Financial Results for Second Quarter 2022
6:19pm
8-K
EX-99.1
d1y8za
1 Aug 22
Emergent Biosolutions Reports Financial Results for Second Quarter 2022
4:11pm
8-K
m69gwgm t7
6 Jul 22
Departure of Directors or Certain Officers
4:09pm
8-K
EX-99
c2zghejm0c9xn7
6 Jul 22
Departure of Directors or Certain Officers
4:09pm